The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...
Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...
In March 2024, Kayla Gonzalez started having an odd sensation behind her right kneecap. At first, she didn’t think much of it. Then, the feeling started to spread. Soon, she had weakness in her calf, ...
ZURICH, Switzerland, Dec. 5, 2025 /PRNewswire/ -- AL-S Pharma, a clinical-stage biotech company dedicated to the development of AP-101 for the treatment of amyotrophic lateral sclerosis (ALS) today ...
On a quiet farm in Erie County, Pennsylvania, 67-year-old Diane Zaczyk used to think nothing of hefting 50-pound sacks of chicken feed onto her shoulder. Strong, stubborn and devoted to caring for her ...
LOS ANGELES, Nov. 4, 2025 /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics designed to restore synapses to improve health in the ...
On Monday, the 52-year-old actor -- who revealed his diagnosis in April -- posted a video on Instagram in collaboration with the organization, I AM ALS, for its Push for Progress campaign, which hopes ...
FAYETTEVILLE -- Even before Thursday's ceremonial ribbon-cutting for the new ALS Clinic at University of Arkansas for Medical Sciences Northwest Hospital, officials and representatives of the ALS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback